These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12718729)

  • 21. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transcorneal drug delivery: prospects for the use of liposomes].
    Aliautdin RN; Iezhitsa IN; Agarval R
    Vestn Oftalmol; 2014; 130(4):117-22. PubMed ID: 25306734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonic study to see the effect of topical pilocarpine and homatropine on anterior chamber depth in phakic cases.
    Mehrotra AS; Gupta IL; Chouhan BS
    Indian J Ophthalmol; 1992; 40(1):5-8. PubMed ID: 1464455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
    Mandal A; Bisht R; Rupenthal ID; Mitra AK
    J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.
    Majumdar S; Duvvuri S; Mitra AK
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1437-52. PubMed ID: 15191791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.
    Jordán J; Ruíz-Moreno JM
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1181-92. PubMed ID: 23647131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticles for drug delivery to the anterior segment of the eye.
    Janagam DR; Wu L; Lowe TL
    Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in ophthalmic drug delivery.
    Morrison PW; Khutoryanskiy VV
    Ther Deliv; 2014 Dec; 5(12):1297-315. PubMed ID: 25531930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular design for enhancement of ocular penetration.
    Shirasaki Y
    J Pharm Sci; 2008 Jul; 97(7):2462-96. PubMed ID: 17918725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An updated patent review on ocular drug delivery systems with potential for commercial viability.
    Srivastava R; Pathak K
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):146-62. PubMed ID: 21453249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model of transient drug diffusion across cornea.
    Zhang W; Prausnitz MR; Edwards A
    J Control Release; 2004 Sep; 99(2):241-58. PubMed ID: 15380634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
    Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
    Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimally invasive, direct, real time measurement of drug concentration in the anterior eye.
    Miller J; Wilson WS; Wilson CG; Uttamchandani D
    Br J Ophthalmol; 2005 Sep; 89(9):1147-51. PubMed ID: 16113370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimally invasive microneedles for ocular drug delivery.
    Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
    Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of hydrophilic contact lenses to increase ocular penetration of topical drugs.
    Waltman SR; Kaufman HE
    Invest Ophthalmol; 1970 Apr; 9(4):250-5. PubMed ID: 5435768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.